Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).

Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).

<h4>Background</h4>Colonoscopy screening is underused by first-degree relatives (FDRs) of patients with non-syndromic colorectal cancer (CRC) with screening completion rates below 50%. Studies conducted in FDR referred for screening suggest that fecal immunochemical testing (FIT) was not...

Full description

Bibliographic Details
Main Authors: Natalia González-López, Enrique Quintero, Antonio Z Gimeno-Garcia, Luis Bujanda, Jesús Banales, Joaquin Cubiella, María Salve-Bouzo, Jesus Miguel Herrero-Rivas, Estela Cid-Delgado, Victoria Alvarez-Sanchez, Alejandro Ledo-Rodríguez, Maria Luisa de-Castro-Parga, Romina Fernández-Poceiro, Luciano Sanromán-Álvarez, Jose Santiago-Garcia, Alberto Herreros-de-Tejada, Teresa Ocaña-Bombardo, Francesc Balaguer, María Rodríguez-Soler, Rodrigo Jover, Marta Ponce, Cristina Alvarez-Urturi, Xavier Bessa, Maria-Pilar Roncales, Federico Sopeña, Angel Lanas, David Nicolás-Pérez, Zaida Adrián-de-Ganzo, Marta Carrillo-Palau, Enrique González-Dávila, Oncology Group of Asociación Española de Gastroenterología
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-10-01
Series:PLoS Medicine
Online Access:https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004298&type=printable

Internet

https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004298&type=printable

Similar Items